NJ AR130 | 2014-2015 | Regular Session
Note: Carry Foward to future AR30
Status
Sponsorship: Partisan Bill (Democrat 2)
Status: Introduced on June 5 2014 - 25% progression, died in committee
Action: 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee
Pending: Assembly Health and Senior Services Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on June 5 2014 - 25% progression, died in committee
Action: 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee
Pending: Assembly Health and Senior Services Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.
Title
Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2014-06-05 | Assembly | Introduced, Referred to Assembly Health and Senior Services Committee |
Same As/Similar To
AR130 (Carry Over) 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee
SR77 (Same As) 2015-02-05 - Filed with Secretary of State
SR77 (Same As) 2015-02-05 - Filed with Secretary of State
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2014/AR130 |
| Text | https://pub.njleg.gov/Bills/2014/AR/130_I1.HTM |
